Literature DB >> 21443897

The role of metabotropic glutamate receptors in addiction: evidence from preclinical models.

Jhodie R Duncan1, Andrew J Lawrence.   

Abstract

Addiction is a chronic disorder characterised by repeated bouts of drug taking, abstinence and relapse. The addicted state may be in part due to drug-induced neuroadaptations in the mesocorticolimbic and corticostriatal pathways. Recently focus has been on the role of aberrant glutamate transmission and its contribution to the hierarchical control over these systems. This review will expand our current knowledge of the most recent advances that have been made in preclinical animal models that provide evidence that implicate metabotropic glutamate receptors (mGluRs) in contributing to the neuroadaptations pertinent to addiction, as well as the role of Homer proteins in regulating these responses. The recent discovery of receptor mosaics will be discussed which add an additional dimension to the complexity of understanding the mechanism of glutamate mediated behaviours. Finally this review introduces a new area related to glutamatergic responses, namely microRNAs, that may become pivotal in directing our future understanding of how to best target intervention strategies to prevent addictive behaviours.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443897     DOI: 10.1016/j.pbb.2011.03.015

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers.

Authors:  Carolina L Haass-Koffler; Kimberly Goodyear; Victoria M Long; Harrison H Tran; Antonella Loche; Roberto Cacciaglia; Robert M Swift; Lorenzo Leggio
Journal:  Eur J Pharm Sci       Date:  2017-08-01       Impact factor: 4.384

2.  Spatial Learning Requires mGlu5 Signalling in the Dorsal Hippocampus.

Authors:  Shawn Zheng Kai Tan; Despina E Ganella; Alec Lindsay Ward Dick; Jhodie R Duncan; Emma Ong-Palsson; Ross A D Bathgate; Jee Hyun Kim; Andrew J Lawrence
Journal:  Neurochem Res       Date:  2015-05-10       Impact factor: 3.996

Review 3.  Neurochemical and neurostructural plasticity in alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2012-04-16       Impact factor: 4.418

Review 4.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

5.  Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humans.

Authors:  Carolina L Haass-Koffler; Kimberly Goodyear; Antonella Loche; Victoria M Long; Carla Lobina; Harrison H Tran; Roberto Cacciaglia; Robert M Swift; Giancarlo Colombo; Lorenzo Leggio
Journal:  J Psychopharmacol       Date:  2018-01-23       Impact factor: 4.153

6.  Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator.

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Lauren E Hood; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2012-07-21       Impact factor: 4.530

7.  Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.

Authors:  L M Hulka; V Treyer; M Scheidegger; K H Preller; M Vonmoos; M R Baumgartner; A Johayem; S M Ametamey; A Buck; E Seifritz; B B Quednow
Journal:  Mol Psychiatry       Date:  2013-04-30       Impact factor: 15.992

8.  An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder.

Authors:  Carolina L Haass-Koffler; Roberta Perciballi; Molly Magill; Antonella Loche; Roberto Cacciaglia; Lorenzo Leggio; Robert M Swift
Journal:  Psychopharmacology (Berl)       Date:  2021-11-03       Impact factor: 4.530

9.  Estradiol mediates dendritic spine plasticity in the nucleus accumbens core through activation of mGluR5.

Authors:  Brittni M Peterson; Paul G Mermelstein; Robert L Meisel
Journal:  Brain Struct Funct       Date:  2014-05-31       Impact factor: 3.270

10.  Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases.

Authors:  Hansen Wang; Min Zhuo
Journal:  Front Pharmacol       Date:  2012-11-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.